Perrigo Company plc [PRGO] vs Dynavax Technologies [DVAX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Perrigo Company plc wins in 9 metrics, Dynavax Technologies Corporation wins in 11 metrics, with 0 ties. Dynavax Technologies Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Perrigo Company plc | Dynavax Technologies Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,818.00 | 54.60 | Dynavax Technologies Corporation |
| Price-to-Book Ratio | 0.55 | 3.41 | Perrigo Company plc |
| Debt-to-Equity Ratio | 131.16 | 54.15 | Dynavax Technologies Corporation |
| PEG Ratio | 0.91 | 0.71 | Dynavax Technologies Corporation |
| EV/EBITDA | 7.26 | 60.37 | Perrigo Company plc |
| Profit Margin (TTM) | -33.51% | -13.13% | Dynavax Technologies Corporation |
| Operating Margin (TTM) | 10.20% | 24.77% | Dynavax Technologies Corporation |
| EBITDA Margin (TTM) | 10.20% | 24.77% | Dynavax Technologies Corporation |
| Return on Equity | -38.66% | -7.14% | Dynavax Technologies Corporation |
| Return on Assets (TTM) | 2.35% | 1.20% | Perrigo Company plc |
| Free Cash Flow (TTM) | $145.10M | $60.16M | Perrigo Company plc |
| Dividend Yield | 9.92% | N/A | N/A |
| 1-Year Return | -58.76% | 20.90% | Dynavax Technologies Corporation |
| Price-to-Sales Ratio (TTM) | 0.38 | 5.51 | Perrigo Company plc |
| Enterprise Value | $4.93B | $1.46B | Perrigo Company plc |
| EV/Revenue Ratio | 1.16 | 4.42 | Perrigo Company plc |
| Gross Profit Margin (TTM) | 32.64% | 84.82% | Dynavax Technologies Corporation |
| Revenue per Share (TTM) | $31 | $3 | Perrigo Company plc |
| Earnings per Share (Diluted) | $-10.12 | $-0.37 | Dynavax Technologies Corporation |
| Beta (Stock Volatility) | 0.49 | 0.93 | Perrigo Company plc |
| Short % of Float | 18.67% | 13.19% | Dynavax Technologies Corporation |
Perrigo Company plc vs Dynavax Technologies Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Perrigo Company plc | -2.64% | -7.84% | 0.85% | 10.08% | -16.67% | -22.97% |
| Dynavax Technologies Corporation | 0.00% | 0.13% | -1.15% | 40.40% | 47.90% | 0.78% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Perrigo Company plc | -58.76% | -68.05% | -76.25% | -88.79% | -86.87% | -34.15% |
| Dynavax Technologies Corporation | 20.90% | 39.64% | 53.92% | -21.40% | -49.68% | -74.59% |
Performance & Financial Health Analysis: Perrigo Company plc vs Dynavax Technologies Corporation
| Metric | PRGO | DVAX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.61B | $1.82B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,169,621 | 2,683,447 |
| 90 Day Avg. Volume | 3,503,450 | 3,501,319 |
| Last Close | $10.70 | $15.50 |
| 52 Week Range | $9.23 - $28.44 | $9.20 - $15.73 |
| % from 52W High | -62.38% | -1.46% |
| All-Time High | $215.73 (Apr 06, 2015) | $106.60 (Nov 27, 2006) |
| % from All-Time High | -95.04% | -85.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.18% |
| Quarterly Earnings Growth | -0.03% | 0.53% |
| Financial Health | ||
| Profit Margin (TTM) | -0.34% | -0.13% |
| Operating Margin (TTM) | 0.10% | 0.25% |
| Return on Equity (TTM) | -0.39% | -0.07% |
| Debt to Equity (MRQ) | 131.16 | 54.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $21.33 | $4.55 |
| Cash per Share (MRQ) | $3.86 | $5.52 |
| Operating Cash Flow (TTM) | $238.50M | $90.63M |
| Levered Free Cash Flow (TTM) | $28.33M | $51.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | 9.92% | N/A |
| Last 12-Month Dividend | $1.16 | N/A |
Valuation & Enterprise Metrics Analysis: Perrigo Company plc vs Dynavax Technologies Corporation
| Metric | PRGO (Apr 24, 2026) | DVAX (Feb 27, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,818.00 | 54.60 |
| Forward P/E | 4.93 | 46.97 |
| PEG Ratio | 0.91 | 0.71 |
| Price to Sales (TTM) | 0.38 | 5.51 |
| Price to Book (MRQ) | 0.55 | 3.41 |
| Market Capitalization | ||
| Market Capitalization | $1.61B | $1.82B |
| Enterprise Value | $4.93B | $1.46B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.16 | 4.42 |
| Enterprise to EBITDA | 7.26 | 60.37 |
| Risk & Other Metrics | ||
| Beta | 0.49 | 0.93 |
| Book Value per Share (MRQ) | $21.33 | $4.55 |
Financial Statements Comparison: Perrigo Company plc vs Dynavax Technologies Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PRGO (2025) | DVAX (2024) |
|---|---|---|
| Revenue/Sales | 4.25B | 277.25M |
| Cost of Goods Sold | 2.76B | 49.45M |
| COGS % of Revenue | 64.9% | 17.8% |
| Gross Profit | 1.49B | 227.80M |
| Gross Margin | 35.1% | 82.2% |
| Research & Development | 95.40M | 61.55M |
| Operating Income (EBIT) | 312.80M | -4.12M |
| Operating Margin | 7.4% | -1.5% |
| EBITDA | 637.10M | 45.70M |
| EBITDA Margin | 15.0% | 16.5% |
| Pre-Tax Income | -1.30B | 30.86M |
| Pre-Tax Income % of Revenue | -30.5% | 11.1% |
| Income Tax | 104.40M | 3.55M |
| Income Tax % of Revenue | 2.5% | 1.3% |
| Net Income (Profit) | -1.43B | 27.31M |
| Profit Margin | -33.5% | 9.9% |
Balance Sheet & Liquidity Metrics
| Metric | PRGO (2025) | DVAX (2024) |
|---|---|---|
| Cash & Equivalents | 531.60M | 95.88M |
| Total Current Assets | 2.80B | 848.94M |
| Total Current Assets % of Revenue | 65.8% | 306.2% |
| Total Current Liabilities | 1.01B | 78.63M |
| Total Current Liabilities % of Revenue | 23.8% | 28.4% |
| Long-Term Debt | 3.60B | 250.24M |
| Long-Term Debt % of Revenue | 84.7% | 90.3% |
| Total Shareholders Equity | 2.94B | 596.80M |
| Retained Earnings | -3.68B | -903.28M |
| Retained Earnings % of Revenue | -86.5% | -325.8% |
| Property, Plant & Equipment | 167.80M | 39.76M |
Cash Flow Statement Comparison
| Metric | PRGO (2025) | DVAX (2024) |
|---|---|---|
| Operating Cash Flow | -1.06B | 69.99M |
| Operating Cash Flow % of Revenue | -24.9% | 25.2% |
| Capital Expenditures | -93.40M | -6.35M |
| Free Cash Flow | 145.10M | 60.16M |
| FCF Margin | 3.4% | 21.7% |
| Debt Repayment | -34.80M | N/A |
| Common Stock Repurchase | N/A | -100.00M |
Short Interest & Institutional Ownership Analysis
| Metric | PRGO | DVAX |
|---|---|---|
| Shares Short | 16.69M | 9.79M |
| Short Ratio | 3.99 | 2.81 |
| Short % of Float | 18.67% | 13.19% |
| Shares Outstanding | 137.62M | 117.36M |
| Float Shares | 136.81M | 100.34M |
| % Held by Insiders | 0.41% | 0.75% |
| % Held by Institutions | 115.48% | 101.55% |
| % Held by Public | -15.89% | -2.30% |
Dividend Analysis & Yield Comparison: Perrigo Company plc vs Dynavax Technologies Corporation
| Metric | PRGO | DVAX |
|---|---|---|
| Last 12-Month Dividend | $1.16 | N/A |
| Last 12-Month Dividend Yield | 9.92% | N/A |
| 3-Year Avg Annual Dividend | $1.12 | N/A |
| 3-Year Avg Dividend Yield | 1.09% | N/A |
| 3-Year Total Dividends | $3.36 | N/A |
| Ex-Dividend Date | Mar 02, 2026 | N/A |